Consensus on the place in therapy of TNF‐α inhibitors in the treatment of patients with chronic plaque psoriasis
Sign Up to like & getrecommendations! Published in 2020 at "Journal of the European Academy of Dermatology and Venereology"
DOI: 10.1111/jdv.16380
Abstract: Biologics are a fundamental therapeutic resource for patients with moderate to severe chronic plaque psoriasis because they well conjugate effectiveness and safety. Several classes of biologics are available, including TNF-α inhibitors (infliximab, etanercept, adalimumab and… read more here.
Keywords: chronic plaque; place therapy; consensus place; tnf inhibitors ... See more keywords